Clinical Trial Update: Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 adaptive TKI therapy trial in thyroid cancer was terminated; results posted previously.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer
• Follicular Thyroid Cancer
• Medullary Thyroid Cancer
• Papillary Thyroid Cancer
• Poorly Differentiated Thyroid Gland Carcinoma
• Thyroid Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Thyroid Cancer, Thyroid Cancer, Medullary | Phase 2 | Status: TERMINATED | Results posted: 2021-01-22